Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT]) Academic Article Article uri icon

Overview

MeSH Major

  • Drug-Eluting Stents
  • Platelet Aggregation Inhibitors

abstract

  • Postprocedural chest pain remains a common problem, and irrespective of electrocardiographic changes, is associated with a higher incidence of early cardiac events. A return to the catheterization laboratory is unlikely to benefit patients with postprocedural chest pain without electrocardiographic changes with documented irreversible intraprocedural complications, or those with late postprocedural pain.

publication date

  • December 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0002-9149(99)00572-X

PubMed ID

  • 10614805

Additional Document Info

start page

  • 1350

end page

  • 3, A8

volume

  • 84

number

  • 11